查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1701234

伴同性診斷市場規模、佔有率、趨勢分析報告：按產品/服務、適應症、技術、產品類型、最終用途、地區、細分市場預測，2025-2030 年

Companion Diagnostics Market Size, Share & Trends Analysis Report By Product And Services, By Indication, By Technology, By Sample Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

伴同性診斷市場的成長與趨勢

根據 Grand View Research, Inc. 的新報告，全球伴同性診斷市場規模預計到 2030 年將達到 159.8 億美元，2025-2030 年期間的複合年成長率為 10.5%。

伴同性診斷是一種專門的測試，旨在透過識別患者體內相應的生物標記來確保特定治療的安全有效使用。這些測試主要用於腫瘤學，以指導臨床醫生根據患者獨特的基因特徵選擇最合適的標靶治療。例如，Foundation Medicine 的 FOUNDATIONONE CDx 分析了 300 多個癌症相關基因，並提供了可為一系列固體癌的精準癌症治療提供資訊的關鍵見解。伴同性診斷可以透過識別重要的突變或基因改變來促進個人化治療方法，從而改善臨床結果並降低副作用的風險。這種個人化的治療方法不僅可以改善患者的護理，而且還支持向精準醫療的更廣泛轉變，其中治療策略根據每個患者獨特的基因組成量身定做。

監管部門的核准在伴同性診斷市場中起著至關重要的作用，尤其是在腫瘤學領域。 2022年8月，美國FDA核准了賽默飛世爾科技的Oncomine Dx Target Test。此伴同性診斷旨在識別非小細胞肺癌腫瘤中的 HER2（ERBB2）活化突變，包括單核苷酸變異和外顯子 20 插入。此類監管部門的核准將檢驗這些測試的臨床效用並促進其廣泛使用。此外，使用次世代定序（NGS）等先進技術對於伴同性診斷至關重要。 NGS 允許臨床醫生同時評估多個基因，從而描述全面的腫瘤分析。美國疾病管制與預防中心 (CDC) 強調，NGS 在過去五年內已成功從研究工具轉變為臨床核准的方法，凸顯了其在診斷應用中日益成長的重要性。

技術創新是伴同性診斷市場成長的關鍵驅動力。主要行業參與企業正在不斷發展其 NGS 平台、數位 ELISA 和液態切片技術，以提高診斷的準確性和效率。例如，2023 年 11 月，QIAGEN 與 Element Biosciences 合作，在其 AVITI 桌上型定序儀系統上提供 NGS 工作流程，旨在增強發現、降低成本並加快基因組研究的周轉時間。同樣，2022 年 1 月，Illumina 與 SomaLogic Operating Co., Inc. 合作，將 SomaScan 蛋白質組學檢測整合到其高通量 NGS 平台中。這些合作不僅擴展了伴同性診斷的技術能力，而且促進了新檢測解決方案開發的創新，並確保新的診斷方法能夠滿足不斷變化的臨床需求。

全球癌症發生率的不斷上升是伴同性診斷應用的重要推動因素。基因組檢測提供了對腫瘤生物學的詳細了解，這對於選擇有效的治療通訊協定至關重要。根據《美國癌症雜誌》的資料，2022年美國將通報約190萬例新發癌症病例，而世界衛生組織（WHO）指出，同年全球將通報226萬例新乳癌病例和221萬例新發肺癌病例。為了應對這些挑戰，正在開發檢測特定基因突變的新測試。例如，2020年8月，美國FDA核准了Guardant360 CDx，這是第一個使用NGS技術檢測轉移性非小細胞肺癌EGFR基因突變的液態切片伴同性診斷。 2023 年 10 月，QIAGEN 與 Myriad Genetics 合作開發腫瘤學領域的先進伴同性診斷解決方案，以增強個人化治療策略並改善患者預後，進一步鞏固了其市場地位。

伴同性診斷市場報告重點

  • 按產品和服務分類，到 2024 年，檢測、套件和試劑將佔據 59.1% 的市場佔有率，引領市場。這些組件對於檢測特定生物標記至關重要，有助於確定患者合格精準治療，尤其是在腫瘤學、心血管疾病和罕見遺傳疾病領域。
  • 從適應症來看，由於全球癌症發生率的上升和個人化醫療需求的不斷成長，預計到 2024 年腫瘤學將佔據絕對的市場佔有率。 CDx 在識別有助於選擇標靶治療和改善癌症患者預後的生物標記方面發揮關鍵作用。
  • 基於技術，聚合酵素鏈鎖反應(PCR) 領域在 2024 年佔據伴同性診斷市場的主導地位，佔有 27.7% 的佔有率。即時PCR因其高特異性和敏感性而被廣泛應用，使其成為識別癌症生物標記的首選方法。
  • 根據樣本類型，組織樣本將在 2024 年佔據最大的市場佔有率，達到 62.7%，這得益於基於生物標記的組織檢測在標靶治療中的廣泛應用。組織樣本對於識別固態腫瘤中的基因突變和蛋白質表現至關重要，可以指導腫瘤學的精準醫療。
  • 根據最終用途，醫院和醫生檢測部門將主導癌症伴同性診斷市場，到 2024 年將佔 38.6% 的佔有率。醫院通常提供全面的癌症診斷測試​​，以應對日益加重的癌症負擔和人口老化問題。
  • 2024 年，北美佔據全球市場主導地位，市場佔有率為 40.2%。主要原因是先進的醫療基礎設施、高昂的醫療支出以及加快新診斷技術核准的強力的法律規範。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章伴同性診斷市場變數、趨勢和範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 伴同性診斷市場分析工具
    • 波特分析
    • PESTEL分析
    • 管道
    • 使用案例

第4章伴同性診斷市場：按產品和服務的估計和趨勢分析

  • 細分儀表板
  • 伴同性診斷市場：2024 年與 2030 年產品與服務趨勢分析
  • 檢測試劑套件和試劑
  • 設備和系統
  • 軟體和服務

第5章伴同性診斷市場：按適應症的估計與趨勢分析

  • 細分儀表板
  • 伴同性診斷市場：2024 年和 2030 年適應症變化分析
  • 腫瘤學
  • 感染疾病
  • 心血管疾病
  • 神經系統疾病
  • 其他

第6章伴同性診斷市場：依技術、估計和趨勢分析

  • 細分儀表板
  • 伴同性診斷市場：2024 年和 2030 年技術變革分析
  • 聚合酵素鏈鎖反應（PCR）
  • 下一代定序（NGS）
  • 原位雜合反應（ISH）
  • 免疫組織化學（IHC）
  • 磁振造影（MRI）
  • 其他

第7章伴同性診斷市場：依樣本類型估算與趨勢分析

  • 細分儀表板
  • 伴同性診斷市場：樣本類型變異分析，2024 年 vs 2030 年
  • 組織樣本
  • 血液樣本
  • 其他

第8章伴同性診斷市場：按最終用途的估計和趨勢分析

  • 細分儀表板
  • 伴同性診斷市場：2024 年與 2030 年最終用途趨勢分析
  • 學術研究中心
  • 醫院和醫生檢查室
  • CRO
  • 參考實驗室
  • 製藥和生物技術公司
  • 其他

第9章伴同性診斷市場：區域、估計和趨勢分析

  • 2024 年及 2030 年伴同性診斷市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • QIAGEN
    • Agilent Technologies, Inc.
    • Abbott
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann La Roche Ltd
    • Foundation Medicine
    • Myriad Genetics
    • Illumina, Inc.
Product Code: GVR-4-68040-536-9

Companion Diagnostics Market Growth & Trends:

The global companion diagnostics market size is expected to reach USD 15.98 billion by 2030, registering a CAGR of 10.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Companion diagnostics are specialized tests designed to ensure the safe and effective use of specific therapeutic products by identifying corresponding biomarkers in patients. These tests are predominantly employed in oncology, where they guide clinicians in selecting the most appropriate targeted therapies based on a patient's unique genetic profile. For instance, Foundation Medicine's FOUNDATIONONE CDx analyzes over 300 cancer-related genes, providing critical insights that inform precision cancer treatments across various solid tumors. By identifying key mutations or genetic alterations, companion diagnostics facilitate personalized treatment regimens, thereby improving clinical outcomes and reducing the risk of adverse reactions. This individualized approach to therapy not only enhances patient care but also supports the broader shift towards precision medicine, where treatment strategies are tailored to the genetic makeup of each patient.

Regulatory approvals play a pivotal role in bolstering the companion diagnostics market, particularly in oncology. In August 2022, the U.S. FDA approved Thermo Fisher Scientific Inc.'s Oncomine Dx Target Test, a companion diagnostic designed to identify HER2 (ERBB2) activating mutations-including single nucleotide variants and exon 20 insertions-in non-small cell lung cancer tumors. Such regulatory endorsements validate the clinical utility of these tests and promote their widespread adoption. Additionally, the use of advanced techniques such as Next-Generation Sequencing (NGS) has become integral to companion diagnostics. NGS enables clinicians to evaluate multiple genes simultaneously, thereby providing comprehensive tumor profiling. The Centers for Disease Control and Prevention (CDC) has highlighted that NGS has successfully transitioned from a research tool to a clinically approved method within the past five years, underscoring its growing importance in diagnostic applications.

Technological innovation is a critical driver of growth in the companion diagnostics market. Key industry players are continuously advancing NGS platforms, digital ELISA, and liquid biopsy techniques to improve diagnostic precision and efficiency. Strategic partnerships are further accelerating these developments; for instance, in November 2023, QIAGEN partnered with Element Biosciences to provide NGS workflows for the benchtop sequencer AVITI System, aiming to enhance discovery, reduce costs, and improve turnaround times in genomic research. Similarly, in January 2022, Illumina Inc. collaborated with SomaLogic Operating Co., Inc. to integrate the SomaScan proteomics assay into its high-throughput NGS platforms. These collaborations not only expand the technological capabilities of companion diagnostics but also foster innovation in the development of new testing solutions, ensuring that emerging diagnostic methods keep pace with evolving clinical needs.

The rising prevalence of cancer globally has significantly spurred the adoption of companion diagnostics, as genomic testing offers a detailed insight into tumor biology that is critical for selecting effective treatment protocols. According to data from the American Cancer Society Journal, approximately 1.9 million new cancer cases were reported in the U.S. in 2022, while the World Health Organization (WHO) noted that in the same year, there were 2.26 million new breast cancer cases and 2.21 million new lung cancer cases worldwide. In response to these challenges, novel tests are being developed to detect specific genetic mutations. For example, in August 2020, the U.S. FDA approved Guardant360 CDx, the first liquid biopsy companion diagnostic that employs NGS technology to detect EGFR gene mutations in metastatic non-small cell lung cancer. In October 2023, QIAGEN further strengthened its market position by partnering with Myriad Genetics to develop advanced companion diagnostic solutions for oncology, thereby enhancing personalized treatment strategies and improving patient outcomes.

Companion Diagnostics Market Report Highlights:

  • Based on product and services segment, assays, kits, and reagents led the market with a 59.1% share in 2024, driven by increasing demand for personalized medicine and targeted therapies. These components are crucial in detecting specific biomarkers that help determine a patient's eligibility for precision treatments, particularly in oncology, cardiovascular diseases, and rare genetic disorders.
  • Based on indication, oncology held the dominant market share in 2024, driven by the increasing global cancer burden and the growing demand for personalized medicine. CDx plays a crucial role in identifying biomarkers that help select targeted therapies, improving treatment outcomes for cancer patients.
  • Based on technology, the Polymerase Chain Reaction (PCR) segment dominated the companion diagnostics market in 2024, holding a 27.7% share. Real-time PCR assays are widely used due to their high specificity and sensitivity, making them a preferred method for identifying cancer biomarkers
  • Based on sample type, tissue samples held the largest market share of 62.7% in 2024, driven by the widespread adoption of biomarker-based tissue testing for targeted therapies. Tissue samples are essential for identifying genetic mutations and protein expressions in solid tumors, guiding precision medicine in oncology.
  • Based on end use, the hospitals and physician laboratories segment dominated the oncology companion diagnostics market, holding a 38.6% share in 2024. Hospitals typically offer a comprehensive range of cancer diagnostic tests to address the increasing cancer burden and aging populations.
  • North America dominated the global market with a market share of 40.2% in 2024. Primarily due to advanced healthcare infrastructure, substantial healthcare expenditure, and a robust regulatory framework that expedites approvals for new diagnostic technologies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Companion Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Companion Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape
    • 3.4.3. Pipeline
    • 3.4.4. Case Study

Chapter 4. Companion Diagnostics Market: Product and Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Companion Diagnostics Market: Product and Services Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Assays, Kits, and Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Instruments and Systems
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software and Services
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Companion Diagnostics Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Companion Diagnostics Market: Indication Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Oncology
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Infectious Diseases
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular Diseases
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Neurological Disorders
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Other Indications
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Companion Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Companion Diagnostics Market: Sample Type Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Polymerase Chain Reaction (PCR)
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Next-generation Sequencing (NGS)
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. In-situ Hybridisation (ISH)
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Immunohistochemistry (IHC)
    • 6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Magnetic Resonance Imaging (MRI)
    • 6.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Other Technology
    • 6.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Companion Diagnostics Market: Sample Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Companion Diagnostics Market: Sample Type Movement Analysis, 2024 & 2030 (USD Million)
  • 7.3. Tissue Samples
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Blood Samples
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Other Sample Types
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Companion Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Companion Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 8.3. Academic and Research Centers
    • 8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Hospitals and Physician Laboratories
    • 8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. CROs
    • 8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Reference Laboratories
    • 8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Pharmaceutical and Biotechnology Companies
    • 8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Other End-use
    • 8.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Companion Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. Companion Diagnostics Market Share, By Region, 2024 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. North America Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. U.S. Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Canada Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Mexico Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. UK Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Germany Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. France Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Italy Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Spain Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Denmark Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Sweden Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Norway Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Japan Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. China Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. India Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Australia Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. South Korea Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Thailand Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Brazil Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Argentina Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. South Africa Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. South Africa Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. UAE Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Kuwait Companion Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
    • 10.4.1. QIAGEN
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product and Services Benchmarking
      • 10.4.1.4. Recent Developments/ Strategic Initiatives
    • 10.4.2. Agilent Technologies, Inc.
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product and Services Benchmarking
      • 10.4.2.4. Recent Developments/ Strategic Initiatives
    • 10.4.3. Abbott
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product and Services Benchmarking
      • 10.4.3.4. Recent Developments/ Strategic Initiatives
    • 10.4.4. Thermo Fisher Scientific, Inc.
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product and Services Benchmarking
      • 10.4.4.4. Recent Developments/ Strategic Initiatives
    • 10.4.5. F. Hoffmann La Roche Ltd
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product and Services Benchmarking
      • 10.4.5.4. Recent Developments/ Strategic Initiatives
    • 10.4.6. Foundation Medicine
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product and Services Benchmarking
      • 10.4.6.4. Recent Developments/ Strategic Initiatives
    • 10.4.7. Myriad Genetics
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product and Services Benchmarking
      • 10.4.7.4. Recent Developments/ Strategic Initiatives
    • 10.4.8. Illumina, Inc.
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product and Services Benchmarking
      • 10.4.8.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global companion diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 4 Global companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 6 Global companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 7 Global companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 North America companion diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 10 North America companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 11 North America companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 13 North America companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 15 U.S. companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 16 U.S. companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 17 U.S. companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 18 U.S. companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Canada companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 20 Canada companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 21 Canada companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Canada companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 23 Canada companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Mexico companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 25 Mexico companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 26 Mexico companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Mexico companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 28 Mexico companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Europe companion diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 31 Europe companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 32 Europe companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Europe companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 34 Europe companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 UK companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 36 UK companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 37 UK companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 38 UK companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 39 UK companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Germany companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 41 Germany companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 42 Germany companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Germany companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 44 Germany companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 France companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 46 France companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 47 France companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 48 France companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 49 France companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Italy companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 51 Italy companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 52 Italy companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Italy companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 54 Italy companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Spain companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 56 Spain companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 57 Spain companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Spain companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 59 Spain companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Denmark companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 61 Denmark companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Denmark companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Denmark companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 64 Denmark companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Sweden companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 66 Sweden companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 67 Sweden companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Sweden companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 69 Sweden companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Norway companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 71 Norway companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 72 Norway companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Norway companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 74 Norway companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific companion diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Japan companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 82 Japan companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 83 Japan companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Japan companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 85 Japan companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 China companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 87 China companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 88 China companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 89 China companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 90 China companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 India companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 92 India companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 93 India companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 94 India companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 95 India companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Australia companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 97 Australia companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 98 Australia companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 99 Australia companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 100 Australia companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 101 South Korea companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 102 South Korea companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 103 South Korea companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 104 South Korea companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 105 South Korea companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 106 Thailand companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 107 Thailand companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 108 Thailand companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Thailand companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 110 Thailand companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 Latin America companion diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 113 Latin America companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 114 Latin America companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 115 Latin America companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 116 Latin America companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 Brazil companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 118 Brazil companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 119 Brazil companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 120 Brazil companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 121 Brazil companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 122 Argentina companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 123 Argentina companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 124 Argentina companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 125 Argentina companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 126 Argentina companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 127 MEA companion diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 129 MEA companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 130 MEA companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 131 MEA companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 132 MEA companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 133 South Africa companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 134 South Africa companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 135 South Africa companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 136 South Africa companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 137 South Africa companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 143 UAE companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 144 UAE companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 145 UAE companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 146 UAE companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 147 UAE companion diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait companion diagnostics market, by product and services, 2018 - 2030 (USD Million)
  • Table 149 Kuwait companion diagnostics market, by indication, 2018 - 2030 (USD Million)
  • Table 150 Kuwait companion diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 151 Kuwait companion diagnostics market, by sample type, 2018 - 2030 (USD Million)
  • Table 152 Kuwait companion diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Companion Diagnostics market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot - 1
  • Fig. 14 Segment snapshot - 2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Companion Diagnostics market: Product and Services outlook key takeaways
  • Fig. 20 Companion Diagnostics market: Product and Services movement analysis
  • Fig. 21 Assays, kits, and reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Instruments and systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Software and services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Companion Diagnostics market: Indication outlook key takeaways
  • Fig. 25 Companion Diagnostics market: Indication movement analysis
  • Fig. 26 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Neurological disorders market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Other Indications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Companion Diagnostics market: Technology outlook key takeaways
  • Fig. 32 Companion Diagnostics market: Technology movement analysis
  • Fig. 33 Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Next-generation Sequencing (NGS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 In-situ Hybridisation (ISH) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Immunohistochemistry (IHC) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Magnetic Resonance Imaging (MRI) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Other technology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Companion Diagnostics market: Sample Type outlook key takeaways
  • Fig. 40 Companion Diagnostics market: Sample Type movement analysis
  • Fig. 41 Tissue samples market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Blood samples market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Other sample types market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Companion Diagnostics market: End-use outlook key takeaways
  • Fig. 45 Companion Diagnostics market: End-use movement analysis
  • Fig. 46 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Diagnostics Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Academic and Research Centers
  • Fig. 50 Hospitals and Physician Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 CROs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Reference Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Pharmaceutical and Biotechnology Companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Other End-use market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 56 Regional marketplace: Key takeaways
  • Fig. 57 North America companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 U.S. companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Canada companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Mexico companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Europe companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 UK companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Germany companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 France companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Spain companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Italy companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Denmark companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Sweden companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Norway companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Asia Pacific companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Japan companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 China companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 India companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Australia companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Korea companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Thailand companion diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Market participant categorization
  • Fig. 96 Companion Diagnostics market position analysis, 2023
  • Fig. 97 Strategic framework